# IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose

> **NCT02130063** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 511 (actual)

## Conditions studied

- Iron Deficiency Anaemia

## Interventions

- **DRUG:** iron isomaltoside 1000 (Monofer®)
- **DRUG:** iron sucrose (Venofer®)

## Key facts

- **NCT ID:** NCT02130063
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2018-09-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130063, "IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02130063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*